Scallan CJ - Search Results

1

What's in a Name? Factors Associated with Documentation and Evaluation of Incidental Pulmonary Nodules.

Iqbal MN, Stott E, Huml AM, Krishnan V, Scallan CJ, Darvesh J, Kode K, Castro C, Turlapati N, Landefeld C, Pencak J, Cedeño M, Baughman W, Sullivan C, Thornton JD. Iqbal MN, et al. Among authors: scallan cj. Ann Am Thorac Soc. 2016 Oct;13(10):1704-1711. doi: 10.1513/AnnalsATS.201602-142OC. Ann Am Thorac Soc. 2016. PMID: 27574734 Free PMC article.

2

The Relationship Between Verified Organ Donor Designation and Patient Demographic and Medical Characteristics.

Sehgal NK, Scallan C, Sullivan C, Cedeño M, Pencak J, Kirkland J, Scott K, Thornton JD. Sehgal NK, et al. Am J Transplant. 2016 Apr;16(4):1294-7. doi: 10.1111/ajt.13608. Epub 2016 Jan 22. Am J Transplant. 2016. PMID: 26603147 Free PMC article. Clinical Trial.

3

Is Signature Size Associated With Organ Donor Designation on Driver's Licenses?

Sehgal NK, Sullivan C, Scallan C, Figueroa M, Pencak JA, Kirkland J, Scott K, Thornton JD. Sehgal NK, et al. Transplant Proc. 2016 Jul-Aug;48(6):1911-5. doi: 10.1016/j.transproceed.2016.02.071. Transplant Proc. 2016. PMID: 27569921 Free PMC article.

4

Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to De Novo Antisynthetase Syndrome.

Scallan C, Venado A, Han L, Xu H, Mulligan M, Raghu G. Scallan C, et al. Ann Am Thorac Soc. 2020 Jul;17(7):901-904. doi: 10.1513/AnnalsATS.202002-126RL. Ann Am Thorac Soc. 2020. PMID: 32437253 No abstract available.

5

Systemic sclerosis-associated interstitial lung disease.

Scallan CJ, Collins BF, Raghu G. Scallan CJ, et al. Curr Opin Pulm Med. 2020 Sep;26(5):487-495. doi: 10.1097/MCP.0000000000000707. Curr Opin Pulm Med. 2020. PMID: 32740379 Review.

6

R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.

Scallan C, Strand L, Hayes J, Kadura S, Collins B, Ho L, Spada C, Canestaro W, Kolb M, Raghu G. Scallan C, et al. Eur Respir J. 2022 Jan 13;59(1):2100917. doi: 10.1183/13993003.00917-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34112729 Free article.

7

A sudden deterioration in idiopathic pulmonary fibrosis.

Scallan CJ, Collins BF, Pipavath S, Upton M, Raghu G. Scallan CJ, et al. Lancet Respir Med. 2021 Nov;9(11):1342. doi: 10.1016/S2213-2600(21)00416-1. Lancet Respir Med. 2021. PMID: 34739887 No abstract available.

8

Connective-Tissue Growth Factor Contributes to TGF-β1-induced Lung Fibrosis.

Yanagihara T, Tsubouchi K, Gholiof M, Chong SG, Lipson KE, Zhou Q, Scallan C, Upagupta C, Tikkanen J, Keshavjee S, Ask K, Kolb MRJ. Yanagihara T, et al. Am J Respir Cell Mol Biol. 2022 Mar;66(3):260-270. doi: 10.1165/rcmb.2020-0504OC. Am J Respir Cell Mol Biol. 2022. PMID: 34797990

9

Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.

Wongkarnjana A, Scallan C, Kolb MRJ. Wongkarnjana A, et al. Curr Opin Pulm Med. 2020 Sep;26(5):436-442. doi: 10.1097/MCP.0000000000000712. Curr Opin Pulm Med. 2020. PMID: 32657838

10

Sputum quantitative cytometry in patients with interstitial lung disease and chronic cough.

Ho T, Scallan C, Rezaee N, Hambly N, Cox PG, Kolb M, Nair P. Ho T, et al. Respir Med. 2020 Aug-Sep;170:106067. doi: 10.1016/j.rmed.2020.106067. Epub 2020 Jun 17. Respir Med. 2020. PMID: 32843182 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters